Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal sinus in cystic fibrosis

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal sinus in cystic fibrosis

Resource Type

CF Research News

Authors

Amanda L Stapleton, Adam J Kimple, Jennifer L Goralski, S Mehdi Nouraie, Barton F Branstetter, Amber D Shaffer, Joseph M Pilewski, Brent A Senior, Stella E Lee, Anna C Zemke

References

J Cyst Fibros. 2022 Mar 14;S1569-1993(22)00051-0. doi: 10.1016/j.jcf.2022.03.002.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Care of patients with CF [3]

Keywords

Highly effective modulator therapy [4]
Sinus disease [5]
Sinusitis [6]

Date

Monday, March 14, 2022

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/elexacaftor-tezacaftor-ivacaftor-improves-sinonasal-sinus-cystic

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-21-00463R2_FINAL_Zemke_200422.pdf [2] https://pubmed.ncbi.nlm.nih.gov/35300931/ [3] https://www.ecfs.eu/research-article-themes/care-patients-cf [4] https://www.ecfs.eu/research-article-keywords/highly-effective-modulator-therapy [5] https://www.ecfs.eu/research-article-keywords/sinus-disease [6] https://www.ecfs.eu/research-article-keywords/sinusitis [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines